New Age Alpha Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
New Age Alpha Advisors, LLC
- $2.27 Trillion
- Q2 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 15,700 shares of VRTX stock, worth $6.09 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
15,700
Previous 13,137
19.51%
Holding current value
$6.09 Million
Previous $6.37 Billion
9.74%
% of portfolio
0.31%
Previous 0.28%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,806Shares Held
239MCall Options Held
1.96MPut Options Held
1.13M-
Capital World Investors Los Angeles, CA28.7MShares$11.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.26 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.25 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.57 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $99.5B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...